|
|
Volumn 4, Issue 7, 2006, Pages 586-590
|
|
Short guideline for Kaposi's sarcoma;Kurzleitlinie - Kaposi-Sarkom
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALITRETINOIN;
ALPHA2A INTERFERON;
ALPHA2B INTERFERON;
ANTINEOPLASTIC AGENT;
ANTIRETROVIRUS AGENT;
BLEOMYCIN;
CYCLOSPORIN A;
DAUNORUBICIN;
DOXORUBICIN;
IMMUNOSUPPRESSIVE AGENT;
INTERFERON;
PACLITAXEL;
RAPAMYCIN;
VINCA ALKALOID;
VINCRISTINE;
ALOPECIA;
ANEMIA;
ARTHRALGIA;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER CLASSIFICATION;
CANCER IMMUNOTHERAPY;
CANCER RADIOTHERAPY;
CANCER SURGERY;
CD4 LYMPHOCYTE COUNT;
CLINICAL PRACTICE;
COBALT THERAPY;
COMPRESSION THERAPY;
CRYOSURGERY;
DEPRESSION;
DISEASE ASSOCIATION;
DRUG HYPERSENSITIVITY;
FEVER;
GRAFT REJECTION;
HAND FOOT SYNDROME;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN HERPESVIRUS 8;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYPOTENSION;
KAPOSI SARCOMA;
LYMPHATIC DRAINAGE;
MYALGIA;
NEUTROPENIA;
ORGAN TRANSPLANTATION;
PERIPHERAL NEUROPATHY;
PHYSIOTHERAPY;
POLYMERASE CHAIN REACTION;
PRACTICE GUIDELINE;
REMISSION;
SKIN CANCER;
TREATMENT OUTCOME;
GERMANY;
HUMANS;
PHYSICIAN'S PRACTICE PATTERNS;
PRACTICE GUIDELINES;
SARCOMA, KAPOSI;
SKIN NEOPLASMS;
TREATMENT OUTCOME;
|
|
EID: 33745424283
PISSN: 16100379
EISSN: 16100387
Source Type: Journal
DOI: 10.1111/j.1610-0387.2006.05566.x Document Type: Article |
|
Times cited : (4)
|
|
References (1)
|
